Brain levels of neuropeptides in human chronic methamphetamine users
- 1 September 2007
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 53 (3) , 447-454
- https://doi.org/10.1016/j.neuropharm.2007.06.009
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- An essential role for ΔFosB in the nucleus accumbens in morphine actionNature Neuroscience, 2006
- Brain antioxidant systems in human methamphetamine usersJournal of Neurochemistry, 2004
- Why is parkinsonism not a feature of human methamphetamine users?Brain, 2004
- Association of Dopamine Transporter Reduction With Psychomotor Impairment in Methamphetamine AbusersAmerican Journal of Psychiatry, 2001
- Neurometabolic Effects of Psilocybin, 3,4-Methylenedioxyethylamphetamine (MDE) and d-Methamphetamine in Healthy Volunteers A Double-Blind, Placebo-Controlled PET Study with [18F]FDGNeuropsychopharmacology, 1999
- Electrochemical Studies of the Effects of Substance P on Dopamine Terminals in the Rat StriatumExperimental Neurology, 1998
- Opioid Receptor Agonists Selective for .MU. and .KAPPA. Receptors Attenuate Methamphetamine-Induced Behavioral Sensitization in the Mouse.Biological & Pharmaceutical Bulletin, 1996
- The neostriatal mosaic: multiple levels of compartmental organizationTrends in Neurosciences, 1992
- Extensive co‐occurrence of substance P and dynorphin in striatal projection neurons: An evolutionarily conserved feature of basal ganglia organizationJournal of Comparative Neurology, 1990
- Neurotensin blocks certain amphetamine-induced behavioursNature, 1981